Assessing the external validity of the VALIDATE-SWEDEHEART trial
By anna [dot] axmon [at] med [dot] lu [dot] se (Anna Axmon) - published 9 July 2021 Photo: Pixabay / Ben Kerckx The VALIDATE-SWEDEHEART trial was a registry-based randomized trial comparing bivalirudin and heparin in patients with acute myocardial infarction undergoing percutaneous coronary intervention. It showed no differences in mortality at 30 or 180 days. This study examines how well the tria
https://www.lupop.lu.se/article/assessing-external-validity-validate-swedeheart-trial - 2025-03-16